2nd, Gendics C. In vivo effect of sustained-release silver
sulphadiazine foam on bioburden and wound closure in infected
venous leg ulcers. J Wound Care 2011;20:90-6.
242. Schraibman IG. The signiﬁcance of beta-haemolytic streptococci in
chronic leg ulcers. Ann R Coll Surg Engl 1990;72:123-4.
243. Manizgate F, Fuller A, Gendics C, Lantis JC 2nd. A prospective
single-center, nonblinded, comparative, postmarket clinical evaluation
of a bovine-derived collagen with ionic silver dressing versus a
carboxymethylcellulose and ionic silver dressing for the reduction of
bioburden in variable-etiology bilateral lower-extremity wounds. Adv
Skin Wound Care 2012;25:220-5.
244. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT,
Westerbos SJ. Topical silver for treating infected wounds. Cochrane
Database Syst Rev 2007;1:CD005486.
245. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J,
Burslem F, et al. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Rep Regen
1999;7:442-52.

JOURNAL OF VASCULAR SURGERY
Volume 60, Number 2S

246. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound
ﬂuids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound ﬂuids.
J Invest Dermatol 1996;107:743-8.
247. Michaels JA, Campbell B, King B, Palfreyman SJ, Shackley P,
Stevenson M. Randomized controlled trial and cost-effectiveness
analysis of silver-donating antimicrobial dressings for ven